Medication info
Lozatine Tablet (Losartan Potassium)

Lozatine Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
HLB Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200501750 · Notified 2005.03.31 · Insurance code 647300240

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment: Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective circulating blood volume: An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective circulating blood volume (intravascular volume depletion) (e.g., patients being treated with diuretics) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily and may be increased up to 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily and may be increased up to 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
HLB Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is effective for the treatment of hypertension, especially in patients with type 2 diabetes who have accompanying kidney complications. It helps stabilize blood pressure, preventing deterioration of kidney function and improving overall health.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment: Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective circulating blood volume: An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective circulating blood volume (intravascular volume depletion) (e.g., patients being treated with diuretics) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily and may be increased up to 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily and may be increased up to 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. Do not administer this medication to patients with severely impaired liver or kidney function, hereditary angioedema, or a history of angioedema, and certain genetically intolerant patients to lactose. Elderly patients, patients with hyperkalemia, liver dysfunction, valvular heart disease or cardiovascular diseases, patients with reduced blood volume, and patients with renal artery stenosis should use this medication with caution, and blood pressure and kidney function should be monitored regularly. This medication is generally well tolerated, but side effects such as dizziness, muscle cramps, back pain, upper respiratory infection, and nasal congestion may occur. Rarely, severe adverse reactions such as angioedema, hepatitis, myalgia, and hyperkalemia have been reported, so if symptoms occur, notify healthcare professionals immediately. This medication lowers blood pressure; therefore, when starting treatment or increasing the dose, there is a risk of hypotension or symptoms of syncope, requiring caution. Drug interactions may occur when taken with other antihypertensives, potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), and lithium, so consult with the prescribing physician. Taking this medication during pregnancy can pose risks of hypotension, kidney dysfunction, and cranial formation anomalies to the fetus, so treatment should be stopped immediately if pregnancy is confirmed, and it is not recommended during breastfeeding. Do not administer this medication to children under 6 years of age or those with severe kidney dysfunction. During treatment with this medication, caution is advised for driving or operating machinery, as dizziness or drowsiness may occur. In the case of overdose, severe hypotension or bradycardia may occur, necessitating immediate medical attention for appropriate treatment. Store this medication out of reach of children, and do not transfer it to another container, as this may compromise its quality.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle spasm
  • back pain
  • limb pain
  • dizziness
  • congestion
Show 124 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • abdominal swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • angioedema
  • palm skin peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • decreased appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • muscle weakness
  • shoulder pain
  • rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • paresthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • skin dryness
  • petechiae
  • erythema
  • flushing
  • photosensitivity
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • increased urinary frequency
  • urethral infection
  • dry cough
  • soft tissue infection
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • erythema multiforme
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia
  • vasculitis
  • anaphylaxis-like syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to ensure the effectiveness of the medication safely.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.